Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Interest Coverage Ratio (2022 - 2025)

Historic Interest Coverage Ratio for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to 2.78.

  • Arcutis Biotherapeutics' Interest Coverage Ratio rose 14728.07% to 2.78 in Q3 2025 from the same period last year, while for Sep 2025 it was 2.61, marking a year-over-year increase of 5779.38%. This contributed to the annual value of 4.73 for FY2024, which is 4175.88% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Interest Coverage Ratio stood at 2.78 for Q3 2025, which was up 14728.07% from 4.82 recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Interest Coverage Ratio high stood at 2.78 for Q3 2025, and its period low was 34.07 during Q1 2022.
  • Moreover, its 4-year median value for Interest Coverage Ratio was 7.88 (2023), whereas its average is 10.63.
  • Over the last 5 years, Arcutis Biotherapeutics' Interest Coverage Ratio had its largest YoY gain of 14728.07% in 2025, and its largest YoY loss of 9457.38% in 2025.
  • Over the past 4 years, Arcutis Biotherapeutics' Interest Coverage Ratio (Quarter) stood at 9.9 in 2022, then rose by 20.36% to 7.88 in 2023, then skyrocketed by 82.55% to 1.37 in 2024, then surged by 301.93% to 2.78 in 2025.
  • Its Interest Coverage Ratio stands at 2.78 for Q3 2025, versus 4.82 for Q2 2025 and 8.23 for Q1 2025.